Opportunities and limitations: the value of pharmacogenetics in clinical practice
MicroRNAs and their relevance to ABC transporters
Understanding genetic variation – the value of systems biology
Clinical implementation of genetic testing in medicine: a US regulatory science perspective
European Medicines Agency initiatives and perspectives on pharmacogenomics
The genetics of pro-arrhythmic adverse drug reactions
Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon
Genetics of platelet inhibitor treatment
Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms
CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials
Use of magnetic resonance imaging in pharmacogenomics
Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer
Implementation of TPMT testing
Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks